United States · FDA National Drug Code directory
Fenbendazole 222 MG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85130-100_337c4554-204a-a725-e063-6394a90a66f5
- Product NDC
- 85130-100
- Form
- CAPSULE
- Composition / generic term
- Fenbendazole 222 MG
- Labeler
- B & L Healthcare Products INC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20150101
- Source listing expiry
- 20261231
Source-listed ingredients
- FENBENDAZOLE — 299.35 mg/mol
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE in 1 BOTTLE, PLASTIC (85130-100-01) / 222 mol in 1 CAPSULE · 85130-100-01
- 90 CAPSULE in 1 BOTTLE, PLASTIC (85130-100-02) / 444 mol in 1 CAPSULE · 85130-100-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →